Company: MDCXW
Filing Date: 2025-09-02
Form Type: 8-K
Source: 0001062993-25-015149
Chunk: 5

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-02
Form: 8-K
Item: Item 9.01
Chunk 5
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                                           
  No.                                                                                                                                                                                                                
  2.1*#        Deed of Variation, dated August 1, 2025, relating to that certain Securities Exchange Agreement, dated June 29, 2025, by and between Antev Limited, the Antev Vendors' Representatives and Medicu...  
  2.2*#        Further Deed of Variation, dated August 15, 2025, relating to that certain Securities Exchange Agreement, dated June 29, 2025, by and between Antev Limited, the Antev Vendors' Representatives a...  
  99.1         Press Release, dated September 2, 2025                                                                                                                                                                
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104          Cover Page Interactive Data File (embedded within the inline XBRL document).                                                                                                                          

  Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) of Regulation S-K. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Secur...  
  Certain schedules and exhibits have been omitted in accordance with Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Excha...  

Forward Looking Statements